Golden State Equity Partners Boosts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Golden State Equity Partners grew its position in CME Group Inc. (NASDAQ:CME - Free Report) by 51.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,468 shares of the financial services provider's stock after purchasing an additional 1,182 shares during the period. Golden State Equity Partners' holdings in CME Group were worth $805,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 97 shares during the last quarter. Truvestments Capital LLC bought a new position in CME Group during the third quarter valued at about $26,000. Dunhill Financial LLC raised its position in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock worth $27,000 after acquiring an additional 81 shares during the period. Fortitude Family Office LLC boosted its stake in CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after acquiring an additional 83 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its stake in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider's stock valued at $43,000 after acquiring an additional 74 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on CME. Citigroup downgraded CME Group from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $235.00 price target on shares of CME Group in a research report on Monday, January 6th. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the stock an "outperform" rating in a report on Thursday, October 24th. Keefe, Bruyette & Woods dropped their price objective on shares of CME Group from $260.00 to $256.00 and set a "market perform" rating on the stock in a report on Monday, January 13th. Finally, Piper Sandler lifted their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 7th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and a consensus target price of $229.27.

CME Group Trading Up 0.3 %

Shares of CME stock opened at $236.52 on Monday. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $249.02. The business's fifty day moving average is $234.73 and its 200 day moving average is $222.63. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $85.23 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 5.28 and a beta of 0.56.

CME Group announced that its Board of Directors has authorized a share repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

CME Group Increases Dividend

The firm also recently declared a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is an increase from CME Group's previous dividend of $2.50. CME Group's dividend payout ratio (DPR) is 48.37%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.